Evidence map›Paper›PMID 26407986›Full record

ArticleImmunologic research2015

Poly(I:C) induces controlled release of IL-36γ from keratinocytes in the absence of cell death.

Ali A Rana, Alexandra V Lucs, James DeVoti, Lionel Blanc, Julien Papoin, Rong Wu, Christopher J Papayannakos, Allan Abramson, Vincent R Bonagura, Bettie M Steinberg

Open access · hybridAbstract read
In one paragraph

Article in Immunologic research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 38 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Article
  5. Epithelial cells release IL-36α in extracellular vesicles following mechanical damage.Biochemical and biophysical research communications · 2022
    Article
  6. Exosome Processing and Characterization Approaches for Research and Technology Development.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Ali A RanaThe Elmezzi Graduate School of Molecular Medicine, 350 Community Drive, Manhasset, NY, 11030, USA.
Alexandra V LucsThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
James DeVotiThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
Lionel BlancThe Elmezzi Graduate School of Molecular Medicine, 350 Community Drive, Manhasset, NY, 11030, USA.
Julien PapoinThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
Rong WuThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
Christopher J PapayannakosThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
Allan AbramsonThe Feinstein Institute for Medical Research, 350 Community Drive, Manhasset, NY, 11030, USA.
Vincent R BonaguraThe Elmezzi Graduate School of Molecular Medicine, 350 Community Drive, Manhasset, NY, 11030, USA.
Bettie M SteinbergThe Elmezzi Graduate School of Molecular Medicine, 350 Community Drive, Manhasset, NY, 11030, USA. bsteinbe@lij.edu.
Feinstein Institute for Medical Research · USHofstra University · USIcahn School of Medicine at Mount Sinai · US

Funding

HPV-Specific, Immune Suppression in Patients with RRPR01DE017227 · NIDCR · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI BONAGURA, VINCENT ROBERT · 2006 to 2017
$4.5M
Reprogramming Host Immune Responses to Cure or Control Persistent HPV InfectionR21AI105987 · NIAID · FEINSTEIN INSTITUTE FOR MEDICAL RESEARCH · PI BONAGURA, VINCENT ROBERT · 2013 to 2014
$589k
NIAID NIH HHS R21 AI105987NIAID NIH HHS R21 AI1105987NIDCR NIH HHS R01 DE017227NIDCR NIH HHS R01 DE017227-06A1
6 · The paper itself

Abstract

The epithelium is part of an integrated immune system where cytokines, toll-like receptors and their ligands, and extracellular vesicles play a crucial role in initiating an innate immune response. IL-36γ is a pro-inflammatory member of the IL-1 family that is mainly expressed by epithelial cells, but regulation of its expression and release are only beginning to be understood. Previous studies reported that IL-36γ is abundant in recurrent respiratory papillomatosis, a rare but devastating disease caused by human papillomaviruses (HPV) types 6 and 11, in which papillomas recurrently grow in and block the airway. Despite the overexpression of IL-36γ, papilloma tissues show no evidence of inflammation, possibly due to suppression of its release by HPVs. We have used primary human foreskin keratinocytes as a model to study IL-36γ regulation in normal epithelial cells. Low doses of poly(I:C) mediate expression and release of IL-36γ without inducing the cell death reported by those using high doses. PKR, an enzyme required for inflammasome activation, does not contribute to controlled release of IL36γ. The keratinocytes secrete IL-36γ in two forms, soluble and in extracellular vesicles. We conclude that there are two separately regulated pathways for the controlled secretion of IL-36γ from keratinocytes, which could contribute to the modulation of both local and systemic immune responses to viruses and other pathogens.

Indexed as

Cell DeathCell Line, TumoreIF-2 KinaseExtracellular VesiclesHumansInterleukin-1KeratinocytesLung NeoplasmsMalePapillomaPoly I-CeIF-2 KinaseIL36G protein, humanInterleukin-1Poly I-CCytokinesIL-36γKeratinocytesPapillomaTLR3

Identifiers

PMID26407986
PMCPMC4648988
OpenAlexW1936711245

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.